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Abstract
Background: Circulating lipoproteins improve the outcome of severe Gram-negative infections through neutralizing
lipopolysaccharides (LPS), thus inhibiting the release of proinflammatory cytokines.
Methods/Principal Findings: Low density lipoprotein receptor deficient (LDLR2/2) mice, with a 7-fold increase in LDL, are
resistant against infection with Salmonella typhimurium (survival 100% vs 5%, p,0.001), and 100 to 1000-fold lower bacterial
burden in the organs, compared with LDLR+/+ mice. Protection was not due to differences in cytokine production,
phagocytosis, and killing of Salmonella organisms. The differences were caused by the excess of lipoproteins, as
hyperlipoproteinemic ApoE2/2 mice were also highly resistant to Salmonella infection. Lipoproteins protect against
infection by interfering with the binding of Salmonella to host cells, and preventing organ invasion. This leads to an altered
biodistribution of the microorganisms during the first hours of infection: after intravenous injection of Salmonella into
LDLR+/+ mice, the bacteria invaded the liver and spleen within 30 minutes of infection. In contrast, in LDLR2/2 mice,
Salmonella remained constrained to the circulation from where they were efficiently cleared, with decreased organ invasion.
Conclusions: plasma lipoproteins are a potent host defense mechanism against invasive Salmonella infection, by blocking
adhesion of Salmonella to the host cells and subsequent tissue invasion.
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Introduction
Salmonella infections are a significant cause of morbidity and
mortality, despite preventive measures and the availability of
antibiotics. A major virulence factor of Salmonella is lipopolysa-
charide (LPS) [1,2], and Salmonella strains with a reduced LPS
expression have a poor growth under stress conditions and are less
virulent [2]. In addition, LPS induces proinflammatory cytokines
and is essential for internalization of Salmonella by host cells [3].
Interaction of LPS with cellular receptors is essential and
therefore, strategies aimed at blocking this interaction may have
a therapeutic potential in invasive infections.
Lipoproteins bind and neutralize bacterial LPS, and they
prevent the induction of potentially harmful proinflammatory
cytokines such as IL-1b and TNFa [4]. In experimental models,
administration of lipoproteins protects against endotoxic shock [5–
7]. Low density lipoprotein receptor deficient (LDLR2/2) mice
have a 7 times higher LDL-cholesterol level than control mice. We
have shown previously that LDLR2/2 mice survive longer and
have lower proinflammatory cytokine concentrations than control
mice after LPS challenge, as well as after infection with Klebsiella
pneumoniae [8]. In addition, LDL administration can protect against
Gram-negative microorganisms through its neutralizing effects on
LPS [9].
Although Salmonella is a Gram-negative organism, the clinical
picture and inflammatory response in systemic Salmonella infections
(e.g., typhoid fever) differs from that in other Gram-negative sepsis
[10]. This is most likely due to the behaviour of Salmonella as
facultative intracellular pathogens, and to the fact that the pattern
of cytokine induction differs from other Gram-negative infections.
In mice, TNFa is undetectable in the circulation until several days
after S. typhimurium infection, whereas TNFa rises at 1 hour after
extracellular Gram-negative infection [11]. The level of cytokine-
mia during Salmonella infections does not reach the toxic levels seen
in endotoxic shock, and inhibition of TNFa during Salmonella
infection worsens the outcome [12,13].
Considering these differences in the pathogenesis of Salmonella
and extracellular Gram-negative infections, one would envisage
either beneficial effects of lipoproteins on the host resistance to
Salmonella through blockade of cellular internalization, or delete-
rious effects by blocking the induction of cytokines by Salmonella
LPS that are required for the activation of host defense. In the
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present study, we investigated the effect of lipoproteins on the
outcome of Salmonella infection.
Methods
Animals
Homozygous C57Bl/6J mice lacking low density lipoprotein
receptors (LDLR2/2) and their wild-type littermates (C57Bl/6J
LDLR+/+) were obtained from Jackson Laboratory (Bar Harbour,
ME) [8]. Homozygous apolipoprotein E (ApoE)-deficient mice on
a C57Bl/6 background were obtained from the Transgenic
Facility of Leiden University Medical Center, Leiden, The
Netherlands [14]. Six to eight weeks old littermate LDLR+/+
and LDLR2/2 mice were used, weighing 20–25 grams. The
animals were fed standard laboratory chow and housed under
specific pathogen free conditions. The experiments were approved
by the Ethics Committee for animal experiments at the Radboud
University Nijmegen.
Salmonella typhimurium infection
A serum-resistant strain of S. typhimurium (phage type 510) was
grown by overnight incubation at 37uC in nutrient broth (BHI
Oxoid). Mice were injected i.v. or i.p. with 16102 cfu of S.
typhimurium. Survival was assessed daily for 21 days in groups of at
least 20 animals. On day 1, 3 and 7 after infection, mice were
killed by cervical dislocation and blood for cytokines or organs for
outgrowth of the microorganisms were collected. For this purpose,
the liver and spleen were removed aseptically, and bone marrow
was flushed from the femur aseptically with 1 ml of sterile saline.
The number of viable Salmonella organisms was determined by
plating several dilutions on Brilliant Green agar (BGA) plates. The
results were expressed as log cfu per gram of tissue.
Distribution of Salmonella cfu
In a separate experiment, Salmonella cfu (105/mouse) were
injected i.v. Distribution was determined in blood, liver and spleen
after 30, 60, 120 and 360 minutes by plating serial dilutions of
blood and homogenized tissue samples on BGA plates. Groups of
5 mice were used for each time point.
Intracellular killing of S. typhimurium by peritoneal
phagocytes
Phagocytosis and intracellular killing of S. typhimurium was
assessed in vitro using peritoneal macrophages and PMN of
LRLR+/+ and LDLR2/2 mice. Exudate peritoneal neutrophils
(PMN) were harvested 4 h after an i.p. injection of 10% proteose
peptone, and exudate macrophages 72 h after i.p. injection of
proteose peptone. 56105 cells in 100 ml of RPMI were dispensed
into 96-well flat bottom plates (Costar) and incubated at 37uC and
5% CO2. To assess phagocytosis, 1610
5 Salmonella organisms/mL
were incubated on the phagocyte monolayers at 37uC in RPMI
with 10% serum. After 15 min, supernatants were aspirated and
the monolayers were gently washed with medium to remove
uningested bacteria. The supernatants were plated on BGA agar
(the non-phagocytozed fraction). To assess intracellular killing, the
wells containing the cells with phagocytosed bacteria were scraped
with a plastic paddle and washed with 200 ml distilled H2O to lyse
the phagocytes. The number of viable bacteria was determined by
plating serial dilutions on BGA plates.
In vitro cytokine production
Resident peritoneal macrophages were harvested from perito-
neal cavity, and cells were resuspended in RPMI 1640 containing
1 mM pyruvate, 2 mM L-glutamine and 100 mg gentamicin per
ml, and incubated (105/well) in 96-wells microtiter plates (Costar).
Heat-killed (30 min, 100uC) S. typhimurium (106 microorganisms in
100 mL of RPMI) were added to peritoneal macrophages and
incubated at 37uC in 5% CO2. After 24 h, the supernatants were
collected and stored at 270uC until assayed. To the macrophages
in the monolayer, 200 mL of RPMI was added and the cells were
disrupted by three freeze-thaw cycles to determine the cell-
associated cytokine contents.
Cytokine measurements
TNFa, IL-1a and IL-1ß concentrations were determined using
specific radioimmunoassays (RIA), as previously described [8]. To
assess cytokine mRNA expression, total RNA from spleen cells
24 hours after infection was isolated as described [15]. The following
primers were used for the PCR reactions: GAPDH, sense, 59–
AACTCCCTCAAGATTGTCAGCA–39, and antisense, 59–TCC-
ACCACCCTGTTGCTGTA–39; TNFa, sense, 59–TCTCAT-
CAGTTCTATGGCCC–39, and antisense, 59–GGGAGTAGA-
CAAGGTACAAC– 39; IL-1a, sense, 59-CAGTTCTGCCATT-
GACCATC-39, and antisense, 59-TCTCACTGAAACTCAG-
CCGT-39, IL–1b, sense, 59–TTGACGGACCCCAAAAGATG–
39, and antisense, 59–AGAAGGTGCTCATGTCCTCA–39 (Euro-
gentec, Seraing, Belgium). After checking the reactions to be in the
log phase, thirty PCR cycles were performed with sets at 92uC for
30 sec., 55uC for 30 sec., and 72uC for 90 sec., using a Mastercycler
5330 (Eppendorf). PCR products were run on 2% agars gels stained
with ethidium bromide. The gels were scanned on a densitometer
(GS–670, Bio-Rad) and analyzed using Molecular Analyst software
(Bio-Rad). The relative amount of TNFa, IL-1a and IL–1b mRNA
in a sample was expressed as a ratio versus the amount of mRNA for
the housekeeping gene GAPDH.
Growth of Salmonella in vitro
To investigate the effect of lipoproteins on microbial growth in
vitro, 0.56103 cfu S. typhimurium in 0.5 mL BHI were incubated
with 0.5 mL of plasma obtained from control C57Bl/6J mice, or
from LDLR2/2 mice and ApoE2/2 mice. After 2, 7, 12 and
24 hours, aliquots of 0.1 mL were removed, serial dilutions were
plated on BGA agar, and cfu were counted after overnight
incubation at 37uC.
Effect of lipoproteins on interaction of Salmonella with
monocytes and endothelial cells
To assess the effect of lipoproteins on the production of
cytokines, S. typhimurium LPS (10 ng/mL; Sigma) and heat-killed
(30 min, 100uC) S. typhimurium (107 organisms/mL) were preincu-
bated with lipoprotein-depleted plasma (LPDP) or isolated LDL
[16] at various concentrations for 60 min, before being added to
the macrophages of LDLR+/+ mice (105/well). The production of
TNFa after 24 h stimulation was measured as described above,
and expressed as relative TNF production compared to controls in
LPDP.
To assess the effect of lipoproteins on the attachment of
Salmonella to vascular endothelial cells, S. typhimurium were
resuspended to 66108/ml in 0.01 mg/ml FITC (Fluka) in
0.05 M carbonate-bicarbonate buffer (pH 9.5). After incubation
for 15 min at room temperature in the dark, FITC-labeled
Salmonella cells were washed twice in PBS containing 1% BSA and
subsequently incubated with isolated 1.1 mmol/L LDL for
4 hours, or with LPDP as a negative control. The human
endothelial cell line (HMEC-1) (CDC Atlanta, GA) was cultured in
MCDB131 medium supplemented with 10% fetal calf serum,
Salmonella and Lipoproteins
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EGF (10 ng/ml), hydrocortison (1 mg/ml), and glutamine at 37uC
and 5% CO2,. 1610
5 HMEC-1 cells were trypsinized and
incubated for 1 hour with 36109 FITC-labeled S. typhimurium,
which were preincubated with either LDL or LPDP. After
incubation, the non-bound Salmonella was thoroughly washed off,
after which the cells were fixated with 2% paraformaldehyde in
PBS and analyzed for binding of FITC-labeled Salmonella by flow
cytometry using the FACScalibur (BD Biosciences).
Statistical analysis
Survival of groups of mice was compared by the Kaplan-Meyer
log-rank test. Differences in concentrations of cytokines and in
organ counts of the microorganisms were analyzed by the Mann-
Whitney U test. Differences were considered significant at P,.05.
All the experiments were at least performed in duplicate.
Results
Outcome of Salmonella infection in LDLR2/2 mice
The total cholesterol concentrations were significantly higher in
the uninfected LDLR2/2 mice than in their wild-type littermates
(9.661.1 mmol/L vs. 2.360.5 mmol/L). After i.v. infection with
102 cfu of S. typhimurium, only 5% of the LDLR2/2 mice died,
whereas the mortality of control LDLR+/+ was 100% within
12 days of infection (P,.001; Fig. 1). A similar difference in
mortality was apparent when mice were infected intraperitoneally
with S. typhimurium (10% mortality in LDLR2/2 mice, vs. 100%
mortality in control LDLR+/+ mice, p,0.01). The reduced
mortality to infection in LDLR2/2 mice was accompanied by a
markedly reduced bacterial load in the organs (Fig. 2). On day 7 of
infection, the differences between the control and LDLR2/2
mice approached 10,000-fold (P,.001; Fig. 2).
Intracellular killing of Salmonella by cells from LDLR+/+
and LDLR2/2 mice in vitro
The numbers of Salmonella CFU phagocytized by neutrophils
and macrophages of LDLR2/2 and LDLR+/+ mice were
similar (Fig. 3A). In addition, the intracellular killing assay
demonstrated that neutrophils and macrophages of LDLR2/2
mice and LDLR+/+ mice did not differ in their ability to kill S.
typhimurium intracellularly (Fig. 3B). The killing rate did not differ
when lipoprotein-rich serum of LDLR2/2 mice was coincubated
with LDLR+/+ control macrophages, and likewise, serum from
LDLR+/+ mice did not affect the killing of Salmonella by LDLR2/
2 macrophages (not shown).
Circulating cytokines during Salmonella infection
On day 1, cytokine concentrations in all samples were under the
detection limit. No detectable concentrations of IL-1ß (,20 pg/
ml) were found at any time point during the infection. On day 3,
IL-1a and TNFa were under the detection limit in LDLR2/2
mice, while TNFa concentrations tended to be slightly higher
(45610 pg/ml) in LDLR+/+ mice (n.s.). On day 7, circulating
concentrations of IL-1a and TNFa were significantly higher in
LDLR+/+ than in LDLR2/2 mice: 95663 pg/ml vs
30610 pg/ml for IL-1a (P,0.02) and 11406290 pg/ml vs
4366 pg/ml for TNFa (P,0.01) (Fig. 4A). These differences
were most likely due to the greater amounts of Salmonella in the
LDLR+/+ mice, leading to increased cytokine stimulation.
Figure 1. LDLR2/2 mice are more resistant to S. typhimurium
infection. Survival of LDLR2/2 and LDLR+/+ C57Bl/6J mice after i.v.
injection of 102 S. typhimurium. n = 20/group.
doi:10.1371/journal.pone.0004237.g001
Figure 2. Outgrowth of S. typhimurium in the organs of LDLR+/+ and LDLR2/2 mice. Outgrowth of S. typhimurium in the liver, spleen and
bone marrow of LDLR2/2 and control (LDLR+/+) C57Bl/6J mice after i.v. injection of 102 cfu. Each point represents the mean6SD for at least 10
animals. Significant differences between LDLR2/2 and LDLR+/+ mice are indicated (*, P,.01; **, P,.001; Mann-Whitney U test).
doi:10.1371/journal.pone.0004237.g002
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Importantly, the differences in cytokine concentrations were not
secondary to an intrinsically deficient cytokine production in the
organs of the LDLR2/2 mice: the amounts of TNF and IL-1b
mRNA in the spleens of LDLR+/+ and LDLR2/2 mice on day
1 of infection was similar (Fig. 4B). No differences in the expression
of IL-1a mRNA were observed either (not shown). In line with
this, peritoneal macrophages of LDLR2/2 and LDLR+/+ mice
stimulated with heat-killed Salmonella produced similar amounts of
TNFa in vitro: unstimulated macrophages, 194691 pg/ml and
186655 pg/ml, macrophages coincubated with heat-killed Salmo-
nella, 5506166 pg/ml and 5206135 pg/ml for LDLR2/2 and
LDLR+/+ mice, respectively (P..05).
Resistance of ApoE2/2 mice to Salmonella infection
To investigate whether the increased lipoprotein concentrations
in another model of hyperlipoproteinemia can also protect against
salmonellosis, hyperlipoproteinemic ApoE2/2 mice (total serum
cholesterol, 16.163.7 vs. 1.960.2 mmol/L [14]) were infected i.v.
with 102 cfu of S. typhimurium. Whereas little differences were
apparent on day 1 of infection, the outgrowth of Salmonella on day
3 and 7 after the infection was 100 to 1000-fold less in the liver and
spleen of ApoE2/2 mice compared to that in ApoE+/+ control
animals (Fig. 5).
Effect of lipoproteins on the growth of S. typhimurium in
vitro
To test whether lipoproteins have a direct inhibitory effect on
the growth of Salmonella, plasma isolated from control mice
(cholesterol concentration 2.3 mmol/L) and hyperlipoproteinemic
plasma from either LDLR2/2 or ApoE2/2 mice (cholesterol
concentrations, 9.6 and 16.1 mmol/L) was added to the culture.
The growth curves of Salmonella were similar in broth with plasma
obtained from all mouse strains (Fig. 6A).
Inhibition of the interaction of Salmonella with
monocytes and endothelial cells by lipoproteins
Because lipoproteins are known to bind and neutralize LPS, we
preincubated Salmonella LPS and heat-killed whole Salmonella
bacteria with LDL at various concentrations, and subsequently
stimulated normal (LDLR+/+) macrophages for cytokine produc-
tion. As shown in Fig. 6B, TNFa production induced by S.
typhimurium is reduced in the presence of elevated LDL
concentrations. To assess the effect of lipoproteins on the
attachment of Salmonella to endothelial cells, FITC-labelled S.
typhimurium was preincubated with LDL. Their attachment to
endothelial cells was significantly reduced compared to that of
Salmonella preincubated with lipoprotein-free plasma, as shown by
both reduction of the percentage of cells binding Salmonella (97%
cells bound LDPD-Salmonella, whereas only 82% cells bound LDL-
Salmonella), as well as the mean fluorescence intensity per cell (41%
reduction, from 56 to 33 conventional units) (see also Fig. 6C).
Protection against organ invasion by Salmonella in
LDLR2/2 mice
To investigate whether hyperlipoproteinemia influences the
early organ invasion from the bloodstream by Salmonella, we
determined the early distribution of the microorganisms after i.v.
injection of 105 S. typhimurium cfu. Blood from LDLR2/2 mice
contained significantly more Salmonella cfu than that of LDLR+/+
mice 30 minutes after injection (P,0.01), but an efficient
elimination of the microorganisms occurred during the next
6 hours (Fig. 7A). The numbers of cfu in the liver and spleen were
70–80% lower in LDLR2/2 mice than those in LDLR+/+ mice
at 30 minutes after injection, and remained lower throughout the
experiment, the difference between mouse strains being significant
at 30, 60, 120 and 360 minutes for the liver (Fig. 7B, P,0.05) and
at 30 and 60 minutes for the spleen (Fig. 7C, P,0.05).
Discussion
In the present study, we demonstrate that hyperlipoproteinemic
mice are resistant against S. typhimurium infection. The protection
was not due to the absence of the LDLR in the knock-out mouse
strain, but to a direct effect of hyperlipoproteinemia. The
beneficial effect of lipoproteins was exerted by blocking the
interaction of Salmonella with host cells, including endothelial cells
and monocytes, which led to inhibition of organ invasion. This
resulted in an altered distribution of the microorganism to the
organs of the host, and increased survival.
It has previously been shown that lipoproteins bind and
neutralize LPS, with beneficial effects in Gram-negative infections
[5–8]. As S. typhimurium is an LPS-containing Gram-negative
bacterium, and Salmonella LPS plays a crucial role in cytokine
stimulation [17] and induction of mortality in vivo [18], an
Figure 3. Phagocytosis and killing of S. typhimurium by
neutrophils and macrophages of LDLR2/2 mice. Phagocytosis
of S. typhimurium after 15 min incubation, and intracellular killing of S.
typhimurium after 4 h, by proteose peptone-elicited peritoneal
neutrophils and macrophages. Data are expressed as percentage of
the initial number of microorganisms. No significant differences
between LDLR2/2 and LDLR+/+ were found.
doi:10.1371/journal.pone.0004237.g003
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improved survival of LDLR2/2 mice during systemic S.
typhimurium infection would have been expected. Indeed,
LDLR2/2 mice were less susceptible to S. typhimurium infection,
but this was not due to blunted cytokine production, as we
observed undetectable or low cytokine circulating concentrations
during the infection in the LDLR2/2 and LDLR+/+ mice. In
addition, the expression of cytokine mRNA was similar in the
organs of LDLR2/2 and LDLR+/+ mice. Thus, the cytokine
response is not responsible for the mortality due to systemic S.
typhimurium infection in this model, and the major difference is the
almost complete absence of Salmonella in the organs of the
LDLR2/2 mice.
The low circulating cytokine response during systemic S.
typhimurium infection may be attributed to the facultative
intracellular nature of the organism. It should be noted that at
later time points during the infection, the LDLR+/+ mice
Figure 4. In-vivo cytokine production in LDLR+/+ and LDLR2/2 mice infected with S. typhimurium. LDLR2/2 and control (LDLR+/+)
C57Bl/6J mice were infected i.v. with 102 cfu of S. typhimurium. After 1, 3 or 7 days, groups of 5 mice/group were sacrificed, and circulating
concentrations of cytokines in the plasma were measured by specific ELISA. In a separate experiment, TNF and IL-1b mRNA in the spleens of LDLR+/+
and LDLR2/2 mice was assessed by semi-quantitative RT-PCR, and expressed as ratio to GAPDH mRNA expression. Data are presented as
means6SD, *p,0.05.
doi:10.1371/journal.pone.0004237.g004
Figure 5. Outgrowth of S. typhimurium in the organs of ApoE+/+
and ApoE2/2 mice. Outgrowth of S. typhimurium in the liver and
spleen of ApoE2/2 and control (ApoE+/+) C57Bl/6J mice after i.v.
injection of 102 cfu. Each point represents the mean6SD for at least 10
animals. Significant differences between ApoE2/2 and ApoE+/+ mice
were found for both liver and spleen on days 3 and 7 (p,0.01).
doi:10.1371/journal.pone.0004237.g005
Figure 6. The effect of LDL on the interaction between S.
typhimurium and the host cells. The growth of S. typhimurium was
identical in plasma harvested from control C57Bl/6, LDLR2/2 or
ApoE2/2 mice (upper panel). Preincubation of Salmonella LPS or heat-
killed S. typhimurium with various concentrations of LDL led to a
significantly diminished stimulation of TNF when added on normal
macrophages (middle panel). Similarly, preincubation of FITC-labelled S.
typhimurium with LDL led to a diminished adhesion of the microor-
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Figure 7. Hyperlipoproteinemia inhibits organ invasion by S. typhimurium. Distribution of S. typhimurium to the blood (cfu/ml), the liver
(cfu/organ), and the spleen (cfu/organ) at various time points after i.v. injection of 105 Salmonella cfu. Each point represents the mean6SD for at least
5 animals. Significant differences between LDLR2/2 and LDLR+/+ mice are indicated (*p,0.05; **p,0.01; Mann-Whitney U test).
doi:10.1371/journal.pone.0004237.g007
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exhibited a greater cytokine response than did LDLR2/2 mice,
and this is likely due to the 1000-fold greater bacterial burden in
the control mice, leading to substantial stimulation of the host
response.
We hypothesized that the decreased bacterial growth in the
LDLR2/2 mice may be a result of enhanced phagocytosis and
intracellular killing of Salmonella organisms in these mice. However,
this proved not to be the case: phagocytosis and subsequent
intracellular killing of the organisms by both neutrophils and
macrophages did not differ between LDLR2/2 and LDLR+/+
mice. Another reason for protection could have been the absence of
the LDL receptor in the knock-out mice. Toxoplasma gondii is known
to use the host LDLR for cholesterol acquisition [19], whereas
penetration of cells by Pseudomonas exotoxin A is mediated through
LDLR-related protein [20,21]. Thus, use of the LDLR by Salmonella
during organ invasion could be envisaged, but was ruled out by the
observation that hyperlipoproteinemic ApoE2/2 mice, which
have an intact LDLR, also were resistant to Salmonella infection. In
addition, LDL affected the adhesion of S. typhimurium to LDLR-
bearing endothelial cells. This demonstrates that elevated lipopro-
tein concentrations, and not the lack of LDLR itself, are responsible
from the resistance of mice against Salmonella infection.
Theoretically, there are several mechanisms that could account
for the beneficial effects of the lipoproteins on Salmonella infection.
Firstly, a direct effect of lipoproteins on the growth of Salmonella
could be envisaged. In this respect, it is of interest that HDL has
been found to be cidal against Trypanosoma cruzi [20]. However, the
growth of Salmonella was similar in the plasma of LDLR2/2,
ApoE2/2 and control mice, excluding a direct antimicrobial
effect of LDL. Secondly, lipoproteins may interact with Salmonella,
putatively with its LPS component, and thus block bacterial
binding and internalization by host cells. As LPS is crucial for the
internalization of Salmonella [22], blocking the interaction between
LPS and host cells may prevent subsequent tissue invasion.
Indeed, preincubation of Salmonella with LDL led to reduced
cytokine production, demonstrating that lipoproteins are able to
inhibit the interaction of Salmonella with monocytes. Even more
relevant for tissue invasion, preincubation of Salmonella with LDL
significantly reduced its attachment to endothelial cells. This
protective mechanism in which lipoproteins block Salmonella
interaction with endothelial cells by their blockade of LPS
represents the same type of mechanism as previously shown by
the blockade of MSCRAMMs (microbial surface components
recognizing adhesive matrix molecules) of Staphylococcus by
naturally occurring antibodies, resulting in the inhibition of
staphylococcal adhesion to endothelial cell and reduced tissue
invasion [23].
Interaction of Salmonella with host cells likely is an important
early step in the pathogenesis of invasive infection. The ability to
infect tissue macrophages has been described as an invasive trait of
intracellular bacteria such as Salmonella spp. [24], and attachment
to endothelial cells is the first step in organ invasion by Salmonella
from the bloodstream. The hypothesis that lipoproteins are able to
directly modify organ invasion by Salmonella, was tested by
assessing early distribution of Salmonella organisms in LDLR2/2
and LDLR+/+ mice after i.v. injection of a large bacterial load.
Indeed, we observed that invasion of Salmonella organisms into the
liver and spleen of LDLR2/2 mice was markedly lower than that
in control mice. The difference in clearance of bacteria between
the two strains of mice was already apparent within 30 minutes
after injection. In this early phase of infection, the numerical
balance between bacterial burden and host defense mechanisms in
the tissues will determine the outcome of infection, and the
LDLR2/2 mice start with a substantial advantage over control
animals. In contrast to the LDLR+/+ mice, the vast majority of
Salmonella organisms in the LDLR2/2 remain sequestrated in the
circulation, where are eliminated by complement and neutrophils,
known to efficiently clear Salmonella from the bloodstream [25].
Blocking tissue invasion by lipoproteins is not unique for Salmonella,
as others have reported that VLDL inhibits liver invasion by
Plasmodium sporozoites, leading to protection against malaria [26].
The precise molecular interaction between Salmonella and
lipoproteins remains to be elucidated, but the bacterial LPS is
the most likely candidate to be involved. Salmonella is known to
interact with host cell Toll-like receptor (TLR)-4 through its LPS
component [17,27], and this signaling mechanism is likely blocked
by binding of lipoproteins to the LPS. The exact nature of the
lipoprotein particle responsible for interaction with Salmonella has
yet to be identified. Phospholipids have been shown to mediate
LPS neutralization, but protein components, such as apolipopro-
tein E, have also been reported to bind LPS [28]. Our findings in
the apoE- and LDLR-deficient mice, which are also protected
against salmonellosis, however, point to a binding site other than
apoE. In addition to TLR4, the macrophage scavenger receptors
[29], and the cystic fibrosis transmembrane conductance regulator
protein [30] are probably involved in the entry of Salmonella into
cells. Whether the interaction of these receptors with Salmonella is
also influenced by lipoproteins remains to be elucidated.
In conclusion, plasma lipoproteins appear to be an important
host defense mechanism against invasive Salmonella infection. A
direct and rapid interaction between lipoproteins and Salmonella in
the bloodstream occurs, preventing the invasion of the microor-
ganisms from the bloodstream into the organs. These new insights
improve the understanding of the pathogenesis of Salmonella
infection, and could ultimately lead to the design of new
therapeutic strategies.
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